Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell acute lymphoblastic leukemia
Biotech
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Wugen is running a pivotal trial to support a 2027 FDA filing for what could be the first off-the-shelf CAR-T for T-cell malignancies.
Nick Paul Taylor
Aug 27, 2025 8:10am
Volatile day for CAR-T biotechs after FDA reveals safety review
Nov 28, 2023 4:35pm
Experimental breast cancer drug could target leukemia, too
Jul 23, 2018 11:00am
In recovery mode, Threshold gets hoped-for licensing deal
Jun 1, 2017 7:14am
